ORMP
Price
$2.35
Change
-$0.06 (-2.49%)
Updated
Oct 4 closing price
33 days until earnings call
XBIT
Price
$7.48
Change
+$0.43 (+6.10%)
Updated
Oct 4 closing price
32 days until earnings call
Ad is loading...

ORMP vs XBIT

Header iconORMP vs XBIT Comparison
Open Charts ORMP vs XBITBanner chart's image
Oramed Pharmaceuticals
Price$2.35
Change-$0.06 (-2.49%)
Volume$77.57K
CapitalizationN/A
XBiotech
Price$7.48
Change+$0.43 (+6.10%)
Volume$19.29K
CapitalizationN/A
View a ticker or compare two or three
ORMP vs XBIT Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ORMP vs. XBIT commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a StrongSell and XBIT is a StrongBuy.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (ORMP: $2.35 vs. XBIT: $7.48)
Brand notoriety: ORMP and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 72% vs. XBIT: 37%
Market capitalization -- ORMP: $99.48M vs. XBIT: $235.48M
ORMP [@Biotechnology] is valued at $99.48M. XBIT’s [@Biotechnology] market capitalization is $235.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 4 TA indicator(s) are bullish while XBIT’s TA Score has 6 bullish TA indicator(s).

  • ORMP’s TA Score: 4 bullish, 5 bearish.
  • XBIT’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, XBIT is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -5.24% price change this week, while XBIT (@Biotechnology) price change was +3.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 08, 2024.

XBIT is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($235M) has a higher market cap than ORMP($99.5M). XBIT YTD gains are higher at: 87.000 vs. ORMP (1.732). ORMP has higher annual earnings (EBITDA): 25.5M vs. XBIT (-41.19M). XBIT has more cash in the bank: 189M vs. ORMP (153M). ORMP has less debt than XBIT: ORMP (486K) vs XBIT (10M). ORMP (0) and XBIT (0) have equivalent revenues.
ORMPXBITORMP / XBIT
Capitalization99.5M235M42%
EBITDA25.5M-41.19M-62%
Gain YTD1.73287.0002%
P/E Ratio4.78N/A-
Revenue00-
Total Cash153M189M81%
Total Debt486K10M5%
FUNDAMENTALS RATINGS
ORMP vs XBIT: Fundamental Ratings
ORMP
XBIT
OUTLOOK RATING
1..100
1526
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5494
PRICE GROWTH RATING
1..100
7338
P/E GROWTH RATING
1..100
999
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (54) in the Pharmaceuticals Other industry is in the same range as XBIT (76) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as XBIT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's SMR Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for XBIT (94) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than XBIT’s over the last 12 months.

XBIT's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for ORMP (73) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew somewhat faster than ORMP’s over the last 12 months.

XBIT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for ORMP (99) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew significantly faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPXBIT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASRE0.130.01
+4.10%
ASTRA ENERGY INC.
ATDRY2.810.04
+1.44%
Auto Trader Group Plc.
KYOCY11.720.04
+0.34%
Kyocera Corp.
ADYEY14.82-0.08
-0.54%
Adyen N.V.
IPOOF1.55-0.02
-1.02%
InPlay Oil Corp.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-2.49%
KRYS - ORMP
48%
Loosely correlated
+0.67%
ALDX - ORMP
45%
Loosely correlated
+2.10%
BPMC - ORMP
44%
Loosely correlated
+0.61%
BTAI - ORMP
44%
Loosely correlated
+6.31%
INO - ORMP
44%
Loosely correlated
-1.77%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with ORMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
+6.10%
ORMP - XBIT
36%
Loosely correlated
-2.49%
AXON - XBIT
34%
Loosely correlated
+1.63%
VBIVQ - XBIT
32%
Poorly correlated
-44.86%
GOSS - XBIT
31%
Poorly correlated
+5.94%
CYTK - XBIT
31%
Poorly correlated
+1.74%
More